AbbVie CDR (CAD Hedged) (ABBV:TSX) closed at $40.83 on November 13, 2026, down 0.39% on the day. The stock trades 2.3% below its 52-week high of $41.81 and 51.8% above its 52-week low of $26.89. Over the past year, it gained 23.6%. AbbVie CDR (CAD Hedged) is part of the Health Care sector.
In 252 trading sessions since November 13, 2025, ABBV closed higher on 136 days (54%). Its best day was June 22, 2026 (+5.94%) and its worst was March 18, 2026 (-5.09%). It never moved 10% or more in a single session. It opened at least 5% above the previous day's high 1 time.
AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas including immunology, oncology, neuroscience and eye care - and products and services in our Allergan Aesthetics portfolio.
Find more stocks like ABBV with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.